Filters
| Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
|---|---|---|---|
Myriad Genetics, Inc. United States | 1 | 1 |
|
Pan-Ethnic Carrier Screen: Full Gene Sequencing and SMA Analysis CEN4GEN Institute for Genomics and Molecular Diagnostics Canada | 1 | 136 |
|
Nemaline Myopathy via the NEB Gene, Exons 82-105 (Triplicate Repeat Region) PreventionGenetics, part of Exact Sciences United States | 1 | 1 |
|
Quantitative Genomic Medicine Laboratories, SL Spain | 326 | 300 |
|
Comprehensive Neuromuscular Panel PreventionGenetics, part of Exact Sciences United States | 376 | 266 |
|
Invitae Comprehensive Myopathy Panel Labcorp Genetics (formerly Invitae) LabCorp United States | 143 | 70 |
|
Invitae Congenital Myopathy Panel Labcorp Genetics (formerly Invitae) LabCorp United States | 58 | 36 |
|
Invitae Comprehensive Neuromuscular Disorders Panel Labcorp Genetics (formerly Invitae) LabCorp United States | 353 | 208 |
|
Nemaline Myopathy (NEM2) via the Nebulin (NEB) Gene PreventionGenetics, part of Exact Sciences United States | 1 | 1 |
|
PreventionGenetics, part of Exact Sciences United States | 10 | 10 |
|
PreventionGenetics, part of Exact Sciences United States | 58 | 42 |
|
Nemaline Myopathy via the NEB exon 55 deletion PreventionGenetics, part of Exact Sciences United States | 1 | 1 |
|
Baylor Genetics United States | 1 | 142 |
|
GeneAware™ Expanded Panel (Female) Baylor Genetics United States | 1 | 422 |
|
GeneAware™ Expanded Panel (Male) Baylor Genetics United States | 1 | 382 |
|
GeneAware™ Expanded Plus Panel (Female) Baylor Genetics United States | 1 | 446 |
|
GeneAware™ Expanded Plus Panel (Male) Baylor Genetics United States | 1 | 401 |
|
Arthrogryposis (NGS panel for 49 genes) CGC Genetics Unilabs Portugal | 1 | 49 |
|
Neuromuscular diseases panel_v.2.0 CGC Genetics Unilabs Portugal | 17 | 248 |
|
CGC Genetics Unilabs Portugal | 1 | 181 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.